Skip to main content
. 2019 Nov 5;30(2):1062–1074. doi: 10.1007/s00330-019-06459-3

Table 2.

Amount and percentage of images for which FFR methods completed successfully (left half of table) and for which the automated methods SIENAX, LST-LPA, and BraTumIA completed successfully (right half of table)

Facial features removal Measurement
AD (n = 110) MS (n = 70) Glioblastoma (n = 84) AD (n = 110)
SIENAX
MS (n = 70)
LST-LPA
Glioblastoma (n = 84)
BraTumIA
Full

110/110

100%

70/70

100%

83/84

99%

QuickShear

110/110

100%

70/70

100%

82/84

98%

110/110

100%

67/70

96%

68/82

83%

FaceMasking

110/110

100%

70/70

100%

83/84

99%

110/110

100%

70/70

100%

81/83

98%

Defacing

110/100

100%

70/70

100%

84/84

100%

110/110

100%

57/70

81%

83/84

99%

AD, Alzheimer’s disease; MS, multiple sclerosis